132 related articles for article (PubMed ID: 26449664)
1. Idiotype-specific CD4(+) T cells eradicate disseminated myeloma.
Haabeth OA; Tveita A; Fauskanger M; Hennig K; Hofgaard PO; Bogen B
Leukemia; 2016 May; 30(5):1216-20. PubMed ID: 26449664
[No Abstract] [Full Text] [Related]
2. A mouse model for immunotherapy of myeloma.
Bogen B
Hematol J; 2002; 3(5):224-9. PubMed ID: 12391539
[TBL] [Abstract][Full Text] [Related]
3. Identification of human idiotype-specific T cells in lymphoma and myeloma.
Weng J; Neelapu SS; Woo AF; Kwak LW
Curr Top Microbiol Immunol; 2011; 344():193-210. PubMed ID: 20549471
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular mechanisms that regulate idiotype expression in myeloma cells.
Lynch RG; Milburn GL
Ann N Y Acad Sci; 1983; 418():346-55. PubMed ID: 6231880
[No Abstract] [Full Text] [Related]
5. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
Dembic Z; Schenck K; Bogen B
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2697-702. PubMed ID: 10706628
[TBL] [Abstract][Full Text] [Related]
6. Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice.
Zeis M; Frenzke H; Schmitz N; Uharek L; Steinmann J
Bone Marrow Transplant; 2002 Feb; 29(3):213-21. PubMed ID: 11859393
[TBL] [Abstract][Full Text] [Related]
7. Suppression of MOPC-167 growth in vivo by immunization against the idiotype of the MOPC-167 myeloma protein.
Sakato N; Hall SH; Eisen HN
Microbiol Immunol; 1979; 23(9):927-31. PubMed ID: 317126
[No Abstract] [Full Text] [Related]
8. Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system.
Rhee Fv
Clin Cancer Res; 2007 Mar; 13(5):1353-5. PubMed ID: 17332275
[No Abstract] [Full Text] [Related]
9. Idiotype-specific T cell immunity. I. Generation of effector and suppressor T lymphocytes reactive with myeloma idiotypic determinants.
Abbas AK; Perry LL; Bach BA; Greene MI
J Immunol; 1980 Mar; 124(3):1160-6. PubMed ID: 6153672
[No Abstract] [Full Text] [Related]
10. Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice.
Zeis M; Steinmann J; Petrela E; Hartung G; Schmitz N; Uharek L
Bone Marrow Transplant; 2001 Feb; 27(3):279-85. PubMed ID: 11277175
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models.
Corthay A; Lundin KU; Munthe LA; Frøyland M; Gedde-Dahl T; Dembic Z; Bogen B
Cancer Immunol Immunother; 2004 Sep; 53(9):759-69. PubMed ID: 15088126
[TBL] [Abstract][Full Text] [Related]
12. [Regulation of immune responses by anti-idiotypic lymphocytes].
Miura T
Rinsho Byori; 1982 Jul; 30(7):749-57. PubMed ID: 6983593
[No Abstract] [Full Text] [Related]
13. Immunotherapy in multiple myeloma: current strategies and future prospects.
Yi Q
Expert Rev Vaccines; 2003 Jun; 2(3):391-8. PubMed ID: 12903804
[TBL] [Abstract][Full Text] [Related]
14. Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor.
Kwak LW; Taub DD; Duffey PL; Bensinger WI; Bryant EM; Reynolds CW; Longo DL
Lancet; 1995 Apr; 345(8956):1016-20. PubMed ID: 7723498
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells in clinical trials for multiple myeloma.
Reichardt VL; Brossart P
Methods Mol Med; 2005; 109():127-36. PubMed ID: 15585918
[TBL] [Abstract][Full Text] [Related]
16. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
Corthay A; Lundin KU; Lorvik KB; Hofgaard PO; Bogen B
Cancer Res; 2009 Jul; 69(14):5901-7. PubMed ID: 19567679
[TBL] [Abstract][Full Text] [Related]
17. Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma.
Guardino AE; Rajapaksa R; Ong KH; Sheehan K; Levy R
Cytotherapy; 2006; 8(3):277-89. PubMed ID: 16793736
[TBL] [Abstract][Full Text] [Related]
18. Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells.
Röllig C; Schmidt C; Bornhäuser M; Ehninger G; Schmitz M; Auffermann-Gretzinger S
J Immunother; 2011 Jan; 34(1):100-6. PubMed ID: 21150718
[TBL] [Abstract][Full Text] [Related]
19. Idiotype-specific T lymphocytes. I. Regulation of antibody production by idiotype-specific H-2-restricted T lymphocytes.
Yamamoto H; Bitoh S; Torii M; Fujimoto S
J Immunol; 1983 Mar; 130(3):1038-42. PubMed ID: 6185567
[TBL] [Abstract][Full Text] [Related]
20. Regulation of myeloma growth in mice by antigen and regulatory idiotopes.
Rubinstein LJ; Bona CA
Cancer Res; 1986 Apr; 46(4 Pt 1):1603-7. PubMed ID: 3948149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
